186 related articles for article (PubMed ID: 10606232)
1. Deletion of the COOH-terminal region of p73alpha enhances both its transactivation function and DNA-binding activity but inhibits induction of apoptosis in mammalian cells.
Ozaki T; Naka M; Takada N; Tada M; Sakiyama S; Nakagawara A
Cancer Res; 1999 Dec; 59(23):5902-7. PubMed ID: 10606232
[TBL] [Abstract][Full Text] [Related]
2. HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter.
Stros M; Ozaki T; Bacikova A; Kageyama H; Nakagawara A
J Biol Chem; 2002 Mar; 277(9):7157-64. PubMed ID: 11748232
[TBL] [Abstract][Full Text] [Related]
3. Function of p73, not of p53, is inhibited by the physical interaction with RACK1 and its inhibitory effect is counteracted by pRB.
Ozaki T; Watanabe K; Nakagawa T; Miyazaki K; Takahashi M; Nakagawara A
Oncogene; 2003 May; 22(21):3231-42. PubMed ID: 12761493
[TBL] [Abstract][Full Text] [Related]
4. Identification of a transactivation activity in the COOH-terminal region of p73 which is impaired in the naturally occurring mutants found in human neuroblastomas.
Takada N; Ozaki T; Ichimiya S; Todo S; Nakagawara A
Cancer Res; 1999 Jun; 59(12):2810-4. PubMed ID: 10383137
[TBL] [Abstract][Full Text] [Related]
5. Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53.
Fillippovich I; Sorokina N; Gatei M; Haupt Y; Hobson K; Moallem E; Spring K; Mould M; McGuckin MA; Lavin MF; Khanna KK
Oncogene; 2001 Jan; 20(4):514-22. PubMed ID: 11313982
[TBL] [Abstract][Full Text] [Related]
6. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.
Di Como CJ; Gaiddon C; Prives C
Mol Cell Biol; 1999 Feb; 19(2):1438-49. PubMed ID: 9891077
[TBL] [Abstract][Full Text] [Related]
7. Two new p73 splice variants, gamma and delta, with different transcriptional activity.
De Laurenzi V; Costanzo A; Barcaroli D; Terrinoni A; Falco M; Annicchiarico-Petruzzelli M; Levrero M; Melino G
J Exp Med; 1998 Nov; 188(9):1763-8. PubMed ID: 9802988
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of naturally occurring mutants (P405R and P425L) of p73alpha and p73beta found in neuroblastoma and lung cancer.
Naka M; Ozaki T; Takada N; Takahashi M; Shishikura T; Sakiyama S; Tada M; Todo S; Nakagawara A
Oncogene; 2001 Jun; 20(27):3568-72. PubMed ID: 11429704
[TBL] [Abstract][Full Text] [Related]
9. Identification of protein kinase A catalytic subunit beta as a novel binding partner of p73 and regulation of p73 function.
Hanamoto T; Ozaki T; Furuya K; Hosoda M; Hayashi S; Nakanishi M; Yamamoto H; Kikuchi H; Todo S; Nakagawara A
J Biol Chem; 2005 Apr; 280(17):16665-75. PubMed ID: 15723830
[TBL] [Abstract][Full Text] [Related]
10. p73 independent of c-Myc represses transcription of platelet-derived growth factor beta-receptor through interaction with NF-Y.
Hackzell A; Uramoto H; Izumi H; Kohno K; Funa K
J Biol Chem; 2002 Oct; 277(42):39769-76. PubMed ID: 12167641
[TBL] [Abstract][Full Text] [Related]
11. Kinase activity-independent suppression of p73alpha by AMP-activated kinase alpha (AMPKalpha).
Lee YG; Lee SW; Sin HS; Kim EJ; Um SJ
Oncogene; 2009 Feb; 28(7):1040-52. PubMed ID: 19079340
[TBL] [Abstract][Full Text] [Related]
12. Full-length p73alpha represses drug-induced apoptosis in small cell lung carcinoma cells.
Nyman U; Sobczak-Pluta A; Vlachos P; Perlmann T; Zhivotovsky B; Joseph B
J Biol Chem; 2005 Oct; 280(40):34159-69. PubMed ID: 16087678
[TBL] [Abstract][Full Text] [Related]
13. Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression.
Uramoto H; Izumi H; Nagatani G; Ohmori H; Nagasue N; Ise T; Yoshida T; Yasumoto K; Kohno K
Biochem J; 2003 Apr; 371(Pt 2):301-10. PubMed ID: 12534345
[TBL] [Abstract][Full Text] [Related]
14. Overproduced p73alpha activates a minimal promoter through a mechanism independent of its transcriptional activity.
Takagi S; Ueda Y; Hijikata M; Shimotohno K
FEBS Lett; 2001 Nov; 509(1):47-52. PubMed ID: 11734204
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of p73 and p53 regulation and effector functions.
Fang L; Lee SW; Aaronson SA
J Cell Biol; 1999 Nov; 147(4):823-30. PubMed ID: 10562283
[TBL] [Abstract][Full Text] [Related]
16. Identification of direct p73 target genes combining DNA microarray and chromatin immunoprecipitation analyses.
Fontemaggi G; Kela I; Amariglio N; Rechavi G; Krishnamurthy J; Strano S; Sacchi A; Givol D; Blandino G
J Biol Chem; 2002 Nov; 277(45):43359-68. PubMed ID: 12213815
[TBL] [Abstract][Full Text] [Related]
17. p73 competes with p53 and attenuates its response in a human ovarian cancer cell line.
Vikhanskaya F; D'Incalci M; Broggini M
Nucleic Acids Res; 2000 Jan; 28(2):513-9. PubMed ID: 10606650
[TBL] [Abstract][Full Text] [Related]
18. MDM2 suppresses p73 function without promoting p73 degradation.
Zeng X; Chen L; Jost CA; Maya R; Keller D; Wang X; Kaelin WG; Oren M; Chen J; Lu H
Mol Cell Biol; 1999 May; 19(5):3257-66. PubMed ID: 10207051
[TBL] [Abstract][Full Text] [Related]
19. UFD2a mediates the proteasomal turnover of p73 without promoting p73 ubiquitination.
Hosoda M; Ozaki T; Miyazaki K; Hayashi S; Furuya K; Watanabe K; Nakagawa T; Hanamoto T; Todo S; Nakagawara A
Oncogene; 2005 Nov; 24(48):7156-69. PubMed ID: 16170377
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of NFkappaB-responsive gene expression by DeltaNp73alpha in p53 null cells.
Tanaka Y; Ota K; Kameoka M; Itaya A; Yoshihara K
Exp Cell Res; 2006 May; 312(8):1254-64. PubMed ID: 16430884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
